Key result
Patients with chronic myocardial infarction and fatty metaplasia demonstrated a significantly smaller percentage of fibrosis compared to those without fat deposition (10.68% vs. 13.83%).
Why the study?
Does mDixon LGE imaging improve the detection of fatty metaplasia and characterization of regional myocardial function compared to conventional LGE in patients with chronic myocardial infarction?
Population
20 subjects with chronic myocardial infarction (infarct age median 60.0 months; range 13.0-90.0 months)
Comparison
Advanced cardiac MR imaging including mDixon LGE… vs Conventional late gadolinium enhancement CMR…
Design
Cohort
Authors
Loading...
Fatty metaplasia may mark less fibrosis in chronic MI; leaves open its role in remodeling and prognosis.
Observational (n=20)
No
Does mDixon LGE imaging improve the detection of fatty metaplasia and characterization of regional myocardial function compared to conventional LGE in patients with chronic myocardial infarction?
Absolute Event Rate: 10.68% vs 13.83%
p-value: p=0.005
Advanced CMR with mDixon imaging enables the detection of fatty metaplasia in chronic myocardial infarction, which is associated with altered regional myocardial deformation and cannot be detected by conventional LGE.
Lapinskas et al. (2017) conducted an observational in Chronic myocardial infarction (n=20). Fatty metaplasia vs. No fatty metaplasia was evaluated on Percentage of fibrosis (p=0.005). Patients with chronic myocardial infarction and fatty metaplasia demonstrated a significantly smaller percentage of fibrosis compared to those without fat deposition (10.68% vs. 13.83%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: